Pelin Mutlu
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in
- Biomaterials 10
- Nanoparticle-Based Drug Delivery 10
-
- Multiple Myeloma Research and Treatments 4
- Hemophilia Treatment and Research 1
- Co-authors
- Ufuk Gündüz (26 shared papers)Serap Yalçın (14 shared papers)Gözde Ünsoy (10 shared papers)Rouhollah Khodadust (8 shared papers)Ayşen Tezcaner (2 shared papers)Önder Öngürü (1 shared paper)Ali Uğur Ural (4 shared papers)Yusuf Baran (3 shared papers)
- Journals
- Biomedicine & Pharmacotherapy (4 papers)ACS Omega (2 papers)Journal of Nanoparticle Research (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)EXCLI journal (1 paper)
- Partner nations
- TürkiyeCyprusUnited States
In The Last Decade
Pelin Mutlu
36 papers receiving 924 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 495
- Pharmaceutical Science 98
- Polymers and Plastics 133
- Molecular Medicine 47
- Biomedical Engineering 146
Countries citing papers authored by Pelin Mutlu
This map shows the geographic impact of Pelin Mutlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pelin Mutlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pelin Mutlu more than expected).
Fields of papers citing papers by Pelin Mutlu
This network shows the impact of papers produced by Pelin Mutlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pelin Mutlu. The network helps show where Pelin Mutlu may publish in the future.
Co-authors
The 25 scholars most cited alongside Pelin Mutlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 297 | |
| 2 | 2014 | 113 | |
| 3 | 2016 | 96 | |
| 4 | 2014 | 67 | |
| 5 | 2014 | 66 | |
| 6 | 2013 | 46 | |
| 7 | 2016 | 37 | |
| 8 | 2014 | 26 | |
| 9 | 2024 | 26 | |
| 10 | 2020 | 17 | |
| 11 | 2009 | 16 | |
| 12 | Poly(amidoamine) (PAMAM) Nanoparticles: Synthesis and Biomedical Applications | 2013 | 13 |
| 13 | 2012 | 12 | |
| 14 | 2015 | 12 | |
| 15 | 2021 | 12 | |
| 16 | 2015 | 9 | |
| 17 | 2023 | 9 | |
| 18 | Detection of XRCC1 gene polymorphisms in Turkish head and neck squamous cell carcinoma patients: a comparative analysis with different populations. | 2015 | 8 |
| 19 | 2011 | 7 | |
| 20 | 2014 | 6 |
About Pelin Mutlu
Pelin Mutlu is a scholar working on Biomaterials, Hematology, Polymers and Plastics, Otorhinolaryngology and Genetics, having authored 38 papers that have together received 941 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (10 papers), Dendrimers and Hyperbranched Polymers (6 papers), Multiple Myeloma Research and Treatments (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Synthesis and biological activity (3 papers), Head and Neck Cancer Studies (3 papers) and Hemophilia Treatment and Research (1 paper). The work is most often cited by research in Biomaterials (495 citations), Pharmaceutical Science (98 citations), Polymers and Plastics (133 citations), Molecular Medicine (47 citations) and Biomedical Engineering (146 citations). Pelin Mutlu has collaborated with scholars based in Türkiye, Cyprus and United States. Frequent co-authors include Ufuk Gündüz, Serap Yalçın, Gözde Ünsoy, Rouhollah Khodadust, Ayşen Tezcaner, Önder Öngürü, Ali Uğur Ural, Yusuf Baran, Arzu Yakar and Güngör Gündüz. Their work appears in journals such as Biomedicine & Pharmacotherapy, ACS Omega, Journal of Nanoparticle Research, Anti-Cancer Agents in Medicinal Chemistry and EXCLI journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.